Back to search

Article

Real-word immunogenicity of a recombinant subunit COVID-19 vaccine and effectiveness against omicron infection: a prospective, multi-centre, longitudinal cohort study in Alzheimer's disease patients

2024-04-02

Abstract excerpt

<h4>Introduction: </h4> Vaccination is an essential strategy against COVID-19 in the current era of emerging variants. This study evaluates the real-world immunogenicity and effectiveness of the recombinant subunit COVID-19 vaccine (Zifivax) in Alzheimer's disease (AD) patients. <h4>Methods: </h4> 249 AD patients were enrolled in a multicentre, longitudinal cohort study. Levels of RBD-IgG, neutralization antibody...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ee7a0aa2-0fdb-51d0-9657-8f221613c0c0
DOI
10.21203/rs.3.rs-4105186/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Real-word immunogenicity of a recombinant subunit COVID-19 vaccine and effectiveness against omicron infection: a prospective, multi-centre, longitudinal cohort study in Alzheimer's disease patientsDOI 10.21203/rs.3.rs-4105186/v1
Select a neighboring publication to make it the new centre.